Authors:
MARSHALL E
HOWELL AH
POWLES R
HUNTER MG
EDWARDS M
WOOD LM
CZAPLEWSKI L
PUTTICK R
WARRINGTON S
BOYCE M
TESTA N
DEXTER TM
LORD BI
MILLAR A
Citation: E. Marshall et al., CLINICAL EFFECTS OF HUMAN MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA MIP-1-ALPHA (LD78) ADMINISTRATION TO HUMANS - A PHASE-I STUDY IN CANCER-PATIENTS AND NORMAL HEALTHY-VOLUNTEERS WITH THE GENETICALLY-ENGINEERED VARIANT, BB-10010, European journal of cancer, 34(7), 1998, pp. 1023-1029
Authors:
ROBERTSON J
WYNN R
CROSS M
HATTON C
LASHFORD LS
WILL AM
DEXTER TM
TESTA N
Citation: J. Robertson et al., ACCELERATED TELOMERE SHORTENING IN YOUNG RECIPIENTS OF ALLOGENEIC BONE-MARROW TRANSPLANT, Bone marrow transplantation, 21, 1998, pp. 827-827
Authors:
SCHONFIELD KP
DUERIG J
RUSHTON G
TESTA N
CHANG J
GALLAGHER JT
Citation: Kp. Schonfield et al., ALPHA(4)BETA(1) INTEGRIN-MEDIATED ADHESION OF CD34(-LEUKEMIA - INFLUENCE OF IL-3() CELLS FROM PATIENTS WITH CHRONIC MYELOID), British Journal of Haematology, 102(1), 1998, pp. 162-162
Authors:
SCHOFIELD KP
HUMPHRIES MJ
DEWYNTER E
TESTA N
GALLAGHER JT
Citation: Kp. Schofield et al., THE EFFECT OF ALPHA(4)BETA(1)-INTEGRIN BINDING SEQUENCES OF FIBRONECTIN ON GROWTH OF CELLS FROM HUMAN HEMATOPOIETIC PROGENITORS, Blood, 91(9), 1998, pp. 3230-3238
Authors:
YOUNG RI
RANSON M
CHANG J
LORD B
TESTA N
SCARFFE JH
Citation: Ri. Young et al., PHASE-II TRIAL OF RHIL-6 (INTERLEUKIN-6) PRIOR TO AND CONCURRENTLY WITH VAD (VINCRISTINE, DOXORUBICIN AND DEXAMETHASONE) CHEMOTHERAPY FOR PATIENTS WITH MULTIPLE-MYELOMA, European journal of cancer, 33(2), 1997, pp. 307-311
Authors:
PIERPAOLI W
BULIAN D
DALLARA A
MARCHETTI B
GALLO F
MORALE MC
TIROLO C
TESTA N
Citation: W. Pierpaoli et al., CIRCADIAN MELATONIN AND YOUNG-TO-OLD PINEAL GRAFTING POSTPONE AGING AND MAINTAIN JUVENILE CONDITIONS OF REPRODUCTIVE FUNCTIONS IN MICE AND RATS, Experimental gerontology, 32(4-5), 1997, pp. 587-602
Authors:
COSTAGLIOLA C
MASTROPASQUA L
STEARDO L
TESTA N
Citation: C. Costagliola et al., FLUOXETINE ORAL-ADMINISTRATION INCREASES INTRAOCULAR-PRESSURE, British journal of ophthalmology, 80(7), 1996, pp. 678-678
Authors:
GHIELMINI M
PETTENGELL R
COUTINHO LH
TESTA N
CROWTHER D
Citation: M. Ghielmini et al., THE EFFECT OF THE GM-CSF IL-3 FUSION PROTEIN PIXY321 ON BONE-MARROW AND CIRCULATING HEMATOPOIETIC-CELLS OF PREVIOUSLY UNTREATED PATIENTS WITH CANCER/, British Journal of Haematology, 93(1), 1996, pp. 6-12
Authors:
DECAMPOS E
RADFORD J
STEWARD W
MILROY R
DOUGAL M
SWINDELL R
TESTA N
THATCHER N
Citation: E. Decampos et al., CLINICAL AND IN-VITRO EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 13(7), 1995, pp. 1623-1631
Authors:
STRAKA C
CARR T
WILL A
COUTINHO L
DEXTER TM
TESTA N
Citation: C. Straka et al., SUCCESSFUL EX-VIVO PURGING OF ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS AND SIMULTANEOUS SURVIVAL OF LONG-TERM CULTURE INITIATING CELLS IN A LONG-TERM BONE-MARROW CULTURE (LTBMC) SYSTEM, Blood, 84(10), 1994, pp. 10000494-10000494
Citation: M. Ryan et al., USE OF BONE-MARROW CLONAL CULTURE TO PREDICT RESPONSE TO G-CSF IN PATIENTS WITH CONGENITAL NEUTROPENIA, British Journal of Haematology, 84, 1993, pp. 67-67
Authors:
PRENDIVILLE J
CROWTHER D
THATCHER N
WOLL PJ
FOX BW
MCGOWN A
TESTA N
STERN P
MCDERMOTT R
POTTER M
PETTIT GR
Citation: J. Prendiville et al., A PHASE-I STUDY OF INTRAVENOUS BRYOSTATIN-1 IN PATIENTS WITH ADVANCEDCANCER, British Journal of Cancer, 68(2), 1993, pp. 418-424